UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
August 25, 2023 10:00 A.M.
Form:
F-3
CIK:
0001611747
Company Name:
BiondVax Pharmaceuticals Ltd.
File Number:
333-274078